Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Acta Biomater. 2017 Apr 20;55:100–108. doi: 10.1016/j.actbio.2017.04.019

Table 1. Peptides selected for screening against NP cells.

Peptide Name Amino Acid Sequence Reported Cell Receptors
GD6 CGG(KQNCLSSRAS)FRGCVRNLRLSR Integrin α3 [32,35,40,44,45]
P4 CGGPPFLMLLKGSTR Integrin α3 [32,35,44,45,71]
p678 CGGFQGVLQNVRFVF Integrin α3 [32,34,35,44,45,71]
cNGQ CGGcMGQGEQc (cyclic) Integrin α3 [32,35,44,45]
AG32 CGGTWYKIAFQRNRK Integrins α2, α6, β1 [27, 29,38]
AG10 CGGNRWHSIYITRFG Integrins α2, α5, α6, β1 [27,29,38]
T1 CGGTTSWSQCSKS Integrin α6 [31,46,47]
AG73 CGGRKRLQVQLSIRT Syndecans [25,27,37,49,53-56,72]
RGD CGGRGDS Integrins α5, αV, α8 [15-18,50,51]
IKVAV CSRARKQAASIKVAVSADR Integrins [33,39,48,49]

Table 1. Laminin-mimetic peptides used for initial screening.